Journal of Personalized Medicine Article From Proteomics to Personalized Medicine: The Importance of Isoflavone Dose and Estrogen Receptor Status in Breast Cancer Cells 1 2, 1,3 4 Maria Ilies, , Alina Uifălean * , Sergiu Pas, ca , Vishnu Mukund Dhople , Michael Lalk 5 , Cristina Adela Iuga 1,2 and Elke Hammer 4,6 1 MedFuture Research Center for Advanced Medicine, Department of Proteomics and Metabolomics, “Iuliu Hat, ieganu” University of Medicine and Pharmacy, no. 4–6 Louis Pasteur st., 400349 Cluj-Napoca, Romania;
[email protected] (M.I.);
[email protected] (S.P.);
[email protected] (C.A.I.) 2 Department of Pharmaceutical Analysis, Faculty of Pharmacy, “Iuliu Hat, ieganu” University of Medicine and Pharmacy, Louis Pasteur Street 6, 400349 Cluj-Napoca, Romania 3 Department of Hematology, “Iuliu Hat, ieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 4 Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Felix-Hausdorff-Straße 8, 17475 Greifswald, Germany;
[email protected] (V.M.D.);
[email protected] (E.H.) 5 Institute of Biochemistry, University of Greifswald, Felix-Hausdorff-Straße 4, 17489 Greifswald, Germany;
[email protected] 6 DZHK (German Center for Cardiovascular Research), Partner Site Greifswald, 17475 Greifswald, Germany * Correspondence:
[email protected] Received: 12 November 2020; Accepted: 17 December 2020; Published: 19 December 2020 Abstract: Continuing efforts are directed towards finding alternative breast cancer chemotherapeutics, with improved safety and efficacy profiles. Soy isoflavones represent promising agents but, despite extensive research, limited information exists regarding their impact on the breast cancer cell proteome. The purpose of this study was to compare the proteomic profiles of MCF-7 (estrogen responsive) and MDA-MB-231 (estrogen non-responsive) breast cancer cells exposed to different concentrations of genistein, daidzein, and a soy seed extract, using a high throughput LC–UDMSE protein profiling approach.